- Reaction score
- 287
But LASIK's pool of customers always had a stable size, while Tsujis pool will become smaller once there is a good treatment to keep your status (which doesn't eventually kill your dick).
Last edited:
Update From The God Himself - Dr. Takashi Tsuji
- Thread starter kingjohn
- Start date
- Reaction score
- 1,242
Interesting that hair ain't worth 300k$, but a heart, liver or something else would be worth much more without even thinking about it and Tsuji is going to clone them all.. Hair is pathetic compared to the other ones. Yes his method, cloning etc won't be comparable and nobody is even close to him like you said in the next 10 years, but something that is at least beneficial to gaining new hair could be more popular and a lower price, but just IF something ever will be capable of forming new hair except Tsuji
Honestly I agree with you, Tsuji’s competitors are years behind him. But if it drops down to 190k, which I see as likely, as their system becomes more streamlined, that would be awesome
Cloning organs is 50 years far away at least.
- Reaction score
- 1,242
"10 years"
- Reaction score
- 984
Now the Video is available with english Language
- Reaction score
- 521
Lol this has already been posted a few days ago. It's old news, but at least it is on topic unlike some who post useless arguments here.
This is very important topic
New clues on stem cell transplant rejection revealed in study
But iPSCs haven't emerged as the cure-all that was originally envisioned, due to unforeseen setbacks, including the surprising preclinical finding that iPSC-derived cell transplants are often rejected, even after being reintroduced into the organism the cells were sourced from.
Scientists have struggled to understand why this rejection occurs. But a new study from the UC San Francisco Transplant and Stem Cell Immunobiology (TSI) Lab, in collaboration with the Laboratory of Transplantation Genomics at the National Heart, Lung, and Blood Institute (NHLBI) and Stanford University, shows that the adult-to-iPSC conversion process can mutate DNA found in tiny cellular structures called mitochondria. These mutations can then trigger an immune response that causes mice and humans to reject iPSCs, and stem cell transplants more generally.
https://medicalxpress.com/news/2019-08-clues-stem-cell-transplant-revealed.html
New clues on stem cell transplant rejection revealed in study
But iPSCs haven't emerged as the cure-all that was originally envisioned, due to unforeseen setbacks, including the surprising preclinical finding that iPSC-derived cell transplants are often rejected, even after being reintroduced into the organism the cells were sourced from.
Scientists have struggled to understand why this rejection occurs. But a new study from the UC San Francisco Transplant and Stem Cell Immunobiology (TSI) Lab, in collaboration with the Laboratory of Transplantation Genomics at the National Heart, Lung, and Blood Institute (NHLBI) and Stanford University, shows that the adult-to-iPSC conversion process can mutate DNA found in tiny cellular structures called mitochondria. These mutations can then trigger an immune response that causes mice and humans to reject iPSCs, and stem cell transplants more generally.
https://medicalxpress.com/news/2019-08-clues-stem-cell-transplant-revealed.html
- Reaction score
- 287
What does this mean for us?
Same dude... god I just want some good news here. I hope Tsuji can produce high density results and comes out within 5 years
- Reaction score
- 2,565
They shouldn't just because of one study.
- Reaction score
- 48
Maybe I am watching too many conspiracy videos haha, but what if Tsuji latest tests aren't so good n they are struggling to get breakthroughs so they are getting people off their backs (breathing down their ears all day long lol) by releasing stories like these exorbitant prices and availability in 10 years as a minimum etc so they can work in peace or not have to directly tell the whole world they are failing? 
Maybe I am watching too many conspiracy videos haha, but what if Tsuji latest tests aren't so good n they are struggling to get breakthroughs so they are getting people off their backs (breathing down their ears all day long lol) by releasing stories like these exorbitant prices and availability in 10 years as a minimum etc so they can work in peace or not have to directly tell the whole world they are failing?
You've been watching too many conspiracy videos.
As for the "whole world" just about nobody even knows this exists.
The simplest and most likely explanation: If the results were bad, then they just wouldn't release it and save themselves tremendous amounts of money.
Stem cells could regenerate organs – but only if the body won’t reject them
Many of the most common diseases, like heart failure, liver failure, Type 1 diabetes and Parkinson’s disease, occur when cells or whole organs fail to do their job. Wouldn’t it be fantastic if it were possible to replace cells in these defunct organs? That is exactly what physician-scientists in the field of regenerative medicine are trying to do.
I am a surgeon and stem cell scientist and am interested in regenerating failing organs with stem cells – because for many diseases we don’t have good treatment options yet.
In a recent paper, my colleagues and I figured out why stem cells derived from a patient’s own tissue are sometimes rejected by their own immune systems. We also developed a solution that we think may solve the problem: stem cells that are stripped of their immune features and can’t trigger rejection.
The search for the ideal starter cell
A few years ago a breakthrough occurred that many scientists believed would help fast-track the goal of regenerating organs. That was the identification of proteins that turn on genes that allowed researchers to reprogram adult cells. These proteins transformed cells back into their embryonic-like stem cell state. This gives them the capacity to turn into almost any cell type – like liver or heart or any other cell of interest.
These stem cells can theoretically be used as an inexhaustible source for cells. Scientists believed these cell products could be used to restore the functions of organs and treat diseases. However, regenerating cells and organs from a patient’s own cells and then returning them to that same patient turned out to be trickier than expected.
Researchers are still debating what is the ideal starting cell type for regenerative medicine. The cells required for these therapies can be grown in bioreactors in the lab. But for cell therapies to succeed, the biggest hurdle we have to overcome is immune rejection.
Like transplanted organs, transplanted cells are susceptible to attacks by the recipient’s immune system. Any cells generated from another individual have different proteins on their surface, called tissue antigens, that tag them as “foreign.”
Once tagged, white blood cells, which defend the body against bacteria, viruses and foreign tissue, target these therapeutic cells for destruction. Physicians use high-dose immunosuppressive drugs to silence this immune response so that patients can tolerate a transplanted organ. But these drugs have significant side effects.
To create cells for use in regenerative medicine, scientists envision large-scale collections of stem cells with diverse characteristics and specific tissue antigens. Then just as blood types can be matched, these cataloged stem cells could be matched to the recipient to avoid the patient’s immune system from rejecting these new cells.
One day, hospitals may have enough cell lines to match patients with stem cells based on tissue types. Whether enough cell lines can be banked to serve the wider patient population and whether this strategy will prevent immune responses is yet to be seen.
http://theconversation.com/stem-cel...-but-only-if-the-body-wont-reject-them-122017
Many of the most common diseases, like heart failure, liver failure, Type 1 diabetes and Parkinson’s disease, occur when cells or whole organs fail to do their job. Wouldn’t it be fantastic if it were possible to replace cells in these defunct organs? That is exactly what physician-scientists in the field of regenerative medicine are trying to do.
I am a surgeon and stem cell scientist and am interested in regenerating failing organs with stem cells – because for many diseases we don’t have good treatment options yet.
In a recent paper, my colleagues and I figured out why stem cells derived from a patient’s own tissue are sometimes rejected by their own immune systems. We also developed a solution that we think may solve the problem: stem cells that are stripped of their immune features and can’t trigger rejection.
The search for the ideal starter cell
A few years ago a breakthrough occurred that many scientists believed would help fast-track the goal of regenerating organs. That was the identification of proteins that turn on genes that allowed researchers to reprogram adult cells. These proteins transformed cells back into their embryonic-like stem cell state. This gives them the capacity to turn into almost any cell type – like liver or heart or any other cell of interest.
These stem cells can theoretically be used as an inexhaustible source for cells. Scientists believed these cell products could be used to restore the functions of organs and treat diseases. However, regenerating cells and organs from a patient’s own cells and then returning them to that same patient turned out to be trickier than expected.
Researchers are still debating what is the ideal starting cell type for regenerative medicine. The cells required for these therapies can be grown in bioreactors in the lab. But for cell therapies to succeed, the biggest hurdle we have to overcome is immune rejection.
Like transplanted organs, transplanted cells are susceptible to attacks by the recipient’s immune system. Any cells generated from another individual have different proteins on their surface, called tissue antigens, that tag them as “foreign.”
Once tagged, white blood cells, which defend the body against bacteria, viruses and foreign tissue, target these therapeutic cells for destruction. Physicians use high-dose immunosuppressive drugs to silence this immune response so that patients can tolerate a transplanted organ. But these drugs have significant side effects.
To create cells for use in regenerative medicine, scientists envision large-scale collections of stem cells with diverse characteristics and specific tissue antigens. Then just as blood types can be matched, these cataloged stem cells could be matched to the recipient to avoid the patient’s immune system from rejecting these new cells.
One day, hospitals may have enough cell lines to match patients with stem cells based on tissue types. Whether enough cell lines can be banked to serve the wider patient population and whether this strategy will prevent immune responses is yet to be seen.
http://theconversation.com/stem-cel...-but-only-if-the-body-wont-reject-them-122017
About immunosuppression problem in stem cells (iPSCs) latest “breakthrough“
New study reveals causes of stem cell transplant rejection
A new study has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.
A new study from the UC San Francisco Transplant and Stem Cell Immunobiology (TSI) Lab, in collaboration with the Laboratory of Transplantation Genomics at the National Heart, Lung, and Blood Institute (NHLBI) and Stanford University, has shown that the adult-to-induced pluripotent stem cells (iPSC) conversion process can mutate DNA found in tiny cellular structures called mitochondria.
https://www.drugtargetreview.com/news/47960/new-study-reveals-clues-stem-cell-transplant-rejection/
Stemson Therapeutics are part of Stanford University.
New study reveals causes of stem cell transplant rejection
A new study has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.
A new study from the UC San Francisco Transplant and Stem Cell Immunobiology (TSI) Lab, in collaboration with the Laboratory of Transplantation Genomics at the National Heart, Lung, and Blood Institute (NHLBI) and Stanford University, has shown that the adult-to-induced pluripotent stem cells (iPSC) conversion process can mutate DNA found in tiny cellular structures called mitochondria.
https://www.drugtargetreview.com/news/47960/new-study-reveals-clues-stem-cell-transplant-rejection/
Stemson Therapeutics are part of Stanford University.
Nothing is irrelevant in science. Many scientists works hard to unlock the potential of stem cells. Stem cell transplant rejection is very big problem. Even Tsuji don’t know how his stem cells will behave in human body.